SMO ClinPlus CO.,LTD.

¥34.19As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301257Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (3.70%)
Div yield 0.43%
ROE 2.35%
Diagnostics & Research
Beta (5Y) 0.93
PE TTM 94.58
TSR TTM (34.60%)
Mkt cap ¥2.701B
ROIC 2.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥36
4.76%
438.21%
Hold 10|11|1|2|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.54
0.54
0.54
0.60
21.08%
11.43%
8.21%
8.86%
Revenue¥M
266.2
264.6
266.7
261.3
(4.81%)
(4.55%)
(2.42%)
(3.77%)
Peers (US$404.9M)
Cap (US$)
PE
500.8M
—
Capital
TTM
5Y
10Y
Leveragex
10.93
0.219
0.216
EBIT/Intx
1.294
0.083
0.108
Own earn%
20.74
(151.27)
(168.93)
Sh yield%
59.26
44.83
45.10
Owners
Insiders/Inst%
1.32
20.73
Short interest%
1.73
SBC / revenue%
5.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
1–6
$1 testx
—
Incr. ROIC%
3